Showing results (1591-1600 of 4,124) with videos related to
Sort By:
Pageof 413
Human Gene Therapy|January 1, 1991
Liability considerations presented by human gene therapyJ G PalmerHuman Gene Therapy|October 3, 2007
Retroviral integration site analysis and the fate of transduced clones in an MDR1 gene therapy protocol targeting metastatic breast cancerJunko Mitsuhashi, Satomi Tsukahara, Rieko Suzuki, et al.Human Gene Therapy|September 1, 2006
Analysis of antitumor activity elicited by vaccination with combinations of interleukin-12 DNA with gp100 DNA or the chemokine CCL21 in vivoLina Elzaouk, Jovan Pavlovic, Karin MoellingHuman Gene Therapy|September 16, 2006
Adipose tissue as a novel target for in vivo gene transfer by adeno-associated viral vectorsHiroaki Mizukami, Jun Mimuro, Tsuyoshi Ogura, et al.Human Gene Therapy|October 13, 2006
DNA vaccines: recent developments and future possibilitiesMargaret A Liu, Britta Wahren, Gunilla B Karlsson HedestamHuman Gene Therapy|October 19, 2006
Limited transgene immune response and long-term expression of human alpha-L-iduronidase in young adult mice with mucopolysaccharidosis type I by liver-directed gene therapyC Di Domenico, D Di Napoli, E Gonzalez Y Reyero, et al.Human Gene Therapy|September 16, 2006
Long-term protective immunity induced against Trypanosoma cruzi infection after vaccination with recombinant adenoviruses encoding amastigote surface protein-2 and trans-sialidaseAlexandre V Machado, Jarbas E Cardoso, Carla Claser, et al.Human Gene Therapy|September 16, 2006
Inhibition of ovarian tumor growth by gene therapy with recombinant soluble vascular endothelial growth factor receptor 2Ying Wu, Zheng-Yu Li, Xia Zhao, et al.Human Gene Therapy|October 21, 2006
Adoptive transfer of chimeric FcepsilonRI gene-modified human T cells for cancer immunotherapyMichele W L Teng, Michael H Kershaw, Jacob T Jackson, et al.Human Gene Therapy|July 17, 2008
An internal polyadenylation signal substantially increases expression levels of lentivirus-delivered transgenes but has the potential to reduce viral titer in a promoter-dependent mannerStefanie Hager, Fiona M Frame, Anne T Collins, et al.Pageof 413